← All trials
NCT02774044
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2016
- Primary completion
- Feb 1, 2019
- Completion date
- May 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 900
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- All India Institute of Medical SciencesLead sponsor
- Chacha Nehru Bal Chikitsalaya, New DelhiCollaborator
- All India Institute of Medical SciencesSponsor investigator
- Postgraduate Institute of Medical Education and ResearchCollaborator
- Lokmanya Tilak Municipal Medical CollegeCollaborator
- Government Medical College, ChandigarhCollaborator
- Wellcome TrustCollaborator
- Lady Hardinge Medical CollegeCollaborator
- All India Institute of Medical SciencesCollaborator
- Hospital for Children, ChennaiCollaborator
- Jawaharlal Institute of Postgraduate Medical Education and ResearchCollaborator
- King Edward Memorial Hospital, MumbaiCollaborator
- Azad UniversityCollaborator
- Rajiv Gandhi University of Health SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.